Rochester, NY, United States of America

Mark Lelental


Average Co-Inventor Count = 2.6

ph-index = 9

Forward Citations = 307(Granted Patents)

Forward Citations (Not Self Cited) = 276(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Penfield, NY (US) (1976 - 1988)
  • Rochester, NY (US) (1977 - 2018)

Company Filing History:


Years Active: 1976-2018

Loading Chart...
51 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Mark Lelental in Bioassay Applications

Introduction

Mark Lelental, a prolific inventor based in Rochester, NY, has made significant contributions to the field of bioassay applications through his extensive work and a remarkable portfolio of 51 patents. His inventions focus on enhancing the sensitivity and efficiency of bioanalytical methods, providing groundbreaking solutions in various research and medical applications.

Latest Patents

Among Lelental's latest inventions are two noteworthy patents. The first one, titled "Catalytic marking nanoparticles for ultrasensitive bioassay applications," discloses a composition that includes dispersible nanoparticles smaller than 500 nm. These nanoparticles consist of a metal catalyst or a metal catalyst precursor, conjugated to a biospecific binding reactant that selectively reacts with a target analyte. This composition also includes a dispersing medium and outlines a method and kit for conducting bioassays.

The second patent, "Ultrasensitive bioanalytical assays based on the use of high-gain catalytic chemical amplification," relates to the development of ultrasensitive bioanalytical assays that employ high-gain catalytic chemical amplification methods. This innovation enables the detection and quantification of target analytes labeled with specific binding reagents or biomarkers comprising a catalyst or a catalyst precursor.

Career Highlights

Mark Lelental has played an integral role in advancing bioassay technologies throughout his career. He has contributed his expertise to reputable organizations, including Eastman Kodak Company and Catassays, where he leveraged his innovative thinking to create cutting-edge solutions.

Collaborations

Throughout his career, Lelental has collaborated with notable professionals, including Henry J. Gysling and David A. Dickinson. These partnerships have fostered a creative environment that has led to the successful development of impactful inventions in the field of bioassays.

Conclusion

Mark Lelental's innovative work and a substantial portfolio of patents illustrate his dedication to advancing the field of bioassay applications. His contributions not only enhance the sensitivity of bioanalytical methods but also pave the way for new research opportunities and breakthroughs in medical diagnostics. As a leading inventor, Lelental continues to influence the landscape of bioassay technology through his ongoing research and innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…